Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1G93A transgenic mice

Yuko Kobayakawa, Kunihiko Sakumi, Kosuke Kajitani, Toshihiko Kadoya, Hidenori Horie, Jun ichi Kira, Yusaku Nakabeppu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Aims: Galectin-1, a member of the β-galactoside-binding lectin family, accumulates in neurofilamentous lesions in the spinal cords of both sporadic and familial amyotrophic lateral sclerosis (ALS) patients with a superoxide dismutase 1 gene (SOD1) mutation (A4V). The aim of this study was to evaluate the roles of endogenous galectin-1 in the pathogenesis of ALS. Methods: Expression of galectin-1 in the spinal cord of mutant SOD1 transgenic (SOD1G93A) mice was examined by pathological analysis, real-time RT-PCR and Western blotting. The effects of galectin-1 deficiency were evaluated by cross-breeding SOD1G93A mice with galectin-1 null (Lgals1-/-) mice. Results: Before ALS-like symptoms developed in SOD1G93A/Lgals1+/+ mice, strong galectin-1 immunoreactivity was observed in swollen motor axons and colocalized with aggregated neurofilaments. Electron microscopic observations revealed that the diameters of swollen motor axons in the spinal cord were significantly smaller in SOD1G93A/Lgals1-/- mice, and there was less accumulation of vacuoles compared with SOD1G93A/Lgals1+/+ mice. In symptomatic SOD1G93A/Lgals1+/+ mice, astrocytes surrounding motor axons expressed a high level of galectin-1. Conclusions: Galectin-1 accumulates in neurofilamentous lesions in SOD1G93A mice, as previously reported in humans with ALS. Galectin-1 accumulation in motor axons occurs before the development of ALS-like symptoms and is associated with early processes of axonal degeneration in SOD1G93A mice. In contrast, galectin-1 expressed in astrocytes may be involved in axonal degeneration during symptom presentation.

Original languageEnglish
Pages (from-to)227-244
Number of pages18
JournalNeuropathology and Applied Neurobiology
Volume41
Issue number2
DOIs
Publication statusPublished - Feb 1 2015

Fingerprint

Galectin 1
Motor Neurons
Transgenic Mice
Amyotrophic Lateral Sclerosis
Axons
Spinal Cord
Astrocytes
Galactosides
Intermediate Filaments
Vacuoles
Lectins
Genes
Breeding
Real-Time Polymerase Chain Reaction
Western Blotting

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Histology
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Cite this

Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1G93A transgenic mice. / Kobayakawa, Yuko; Sakumi, Kunihiko; Kajitani, Kosuke; Kadoya, Toshihiko; Horie, Hidenori; Kira, Jun ichi; Nakabeppu, Yusaku.

In: Neuropathology and Applied Neurobiology, Vol. 41, No. 2, 01.02.2015, p. 227-244.

Research output: Contribution to journalArticle

@article{eff7ba58c9f94d64bc8b2f35189ff07e,
title = "Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1G93A transgenic mice",
abstract = "Aims: Galectin-1, a member of the β-galactoside-binding lectin family, accumulates in neurofilamentous lesions in the spinal cords of both sporadic and familial amyotrophic lateral sclerosis (ALS) patients with a superoxide dismutase 1 gene (SOD1) mutation (A4V). The aim of this study was to evaluate the roles of endogenous galectin-1 in the pathogenesis of ALS. Methods: Expression of galectin-1 in the spinal cord of mutant SOD1 transgenic (SOD1G93A) mice was examined by pathological analysis, real-time RT-PCR and Western blotting. The effects of galectin-1 deficiency were evaluated by cross-breeding SOD1G93A mice with galectin-1 null (Lgals1-/-) mice. Results: Before ALS-like symptoms developed in SOD1G93A/Lgals1+/+ mice, strong galectin-1 immunoreactivity was observed in swollen motor axons and colocalized with aggregated neurofilaments. Electron microscopic observations revealed that the diameters of swollen motor axons in the spinal cord were significantly smaller in SOD1G93A/Lgals1-/- mice, and there was less accumulation of vacuoles compared with SOD1G93A/Lgals1+/+ mice. In symptomatic SOD1G93A/Lgals1+/+ mice, astrocytes surrounding motor axons expressed a high level of galectin-1. Conclusions: Galectin-1 accumulates in neurofilamentous lesions in SOD1G93A mice, as previously reported in humans with ALS. Galectin-1 accumulation in motor axons occurs before the development of ALS-like symptoms and is associated with early processes of axonal degeneration in SOD1G93A mice. In contrast, galectin-1 expressed in astrocytes may be involved in axonal degeneration during symptom presentation.",
author = "Yuko Kobayakawa and Kunihiko Sakumi and Kosuke Kajitani and Toshihiko Kadoya and Hidenori Horie and Kira, {Jun ichi} and Yusaku Nakabeppu",
year = "2015",
month = "2",
day = "1",
doi = "10.1111/nan.12123",
language = "English",
volume = "41",
pages = "227--244",
journal = "Neuropathology and Applied Neurobiology",
issn = "0305-1846",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1G93A transgenic mice

AU - Kobayakawa, Yuko

AU - Sakumi, Kunihiko

AU - Kajitani, Kosuke

AU - Kadoya, Toshihiko

AU - Horie, Hidenori

AU - Kira, Jun ichi

AU - Nakabeppu, Yusaku

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Aims: Galectin-1, a member of the β-galactoside-binding lectin family, accumulates in neurofilamentous lesions in the spinal cords of both sporadic and familial amyotrophic lateral sclerosis (ALS) patients with a superoxide dismutase 1 gene (SOD1) mutation (A4V). The aim of this study was to evaluate the roles of endogenous galectin-1 in the pathogenesis of ALS. Methods: Expression of galectin-1 in the spinal cord of mutant SOD1 transgenic (SOD1G93A) mice was examined by pathological analysis, real-time RT-PCR and Western blotting. The effects of galectin-1 deficiency were evaluated by cross-breeding SOD1G93A mice with galectin-1 null (Lgals1-/-) mice. Results: Before ALS-like symptoms developed in SOD1G93A/Lgals1+/+ mice, strong galectin-1 immunoreactivity was observed in swollen motor axons and colocalized with aggregated neurofilaments. Electron microscopic observations revealed that the diameters of swollen motor axons in the spinal cord were significantly smaller in SOD1G93A/Lgals1-/- mice, and there was less accumulation of vacuoles compared with SOD1G93A/Lgals1+/+ mice. In symptomatic SOD1G93A/Lgals1+/+ mice, astrocytes surrounding motor axons expressed a high level of galectin-1. Conclusions: Galectin-1 accumulates in neurofilamentous lesions in SOD1G93A mice, as previously reported in humans with ALS. Galectin-1 accumulation in motor axons occurs before the development of ALS-like symptoms and is associated with early processes of axonal degeneration in SOD1G93A mice. In contrast, galectin-1 expressed in astrocytes may be involved in axonal degeneration during symptom presentation.

AB - Aims: Galectin-1, a member of the β-galactoside-binding lectin family, accumulates in neurofilamentous lesions in the spinal cords of both sporadic and familial amyotrophic lateral sclerosis (ALS) patients with a superoxide dismutase 1 gene (SOD1) mutation (A4V). The aim of this study was to evaluate the roles of endogenous galectin-1 in the pathogenesis of ALS. Methods: Expression of galectin-1 in the spinal cord of mutant SOD1 transgenic (SOD1G93A) mice was examined by pathological analysis, real-time RT-PCR and Western blotting. The effects of galectin-1 deficiency were evaluated by cross-breeding SOD1G93A mice with galectin-1 null (Lgals1-/-) mice. Results: Before ALS-like symptoms developed in SOD1G93A/Lgals1+/+ mice, strong galectin-1 immunoreactivity was observed in swollen motor axons and colocalized with aggregated neurofilaments. Electron microscopic observations revealed that the diameters of swollen motor axons in the spinal cord were significantly smaller in SOD1G93A/Lgals1-/- mice, and there was less accumulation of vacuoles compared with SOD1G93A/Lgals1+/+ mice. In symptomatic SOD1G93A/Lgals1+/+ mice, astrocytes surrounding motor axons expressed a high level of galectin-1. Conclusions: Galectin-1 accumulates in neurofilamentous lesions in SOD1G93A mice, as previously reported in humans with ALS. Galectin-1 accumulation in motor axons occurs before the development of ALS-like symptoms and is associated with early processes of axonal degeneration in SOD1G93A mice. In contrast, galectin-1 expressed in astrocytes may be involved in axonal degeneration during symptom presentation.

UR - http://www.scopus.com/inward/record.url?scp=84921732232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921732232&partnerID=8YFLogxK

U2 - 10.1111/nan.12123

DO - 10.1111/nan.12123

M3 - Article

C2 - 24707896

AN - SCOPUS:84921732232

VL - 41

SP - 227

EP - 244

JO - Neuropathology and Applied Neurobiology

JF - Neuropathology and Applied Neurobiology

SN - 0305-1846

IS - 2

ER -